#ASH24: Beam discloses first clinical data on base-edited sickle cell therapy, one patient death

Beam Therapeutics gave an initial look at the first handful of patients who received its experimental gene-edited treatment for sickle cell disease. As of July 2, six people with severe sickle cell disease have been ...